1. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis
   Jino Park et al, 2015, Oncotarget CrossRef
2. Sepsis induces variation of intestinal barrier function in different phase through nuclear factor kappa B signaling
   Ying-Ya Cao et al, 2021, The Korean Journal of Physiology & Pharmacology CrossRef
3. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer
   Vrajesh Pandya et al, 2016, Oncotarget CrossRef
4. Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
   Long Chen et al, 2022, Frontiers in Oncology CrossRef
5. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer
   Elisabeth Gruber et al, 2019, Cells CrossRef
6. Chaperone-mediated autophagy substrate proteins in cancer
   Ying Tang et al, 2017, Oncotarget CrossRef
7. Involvement of AF1q/MLLT11 in the progression of ovarian cancer
   Paola Tiberio et al, 2017, Oncotarget CrossRef